ArticleHepatology international2018

Efficacy and safety of sofosbuvir plus daclatasvir with or without ribavirin: large real-life results of patients with chronic hepatitis C genotype 4.

Adel Abdel-Moneim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.